Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation-Reference-Cited by-同舟云学术

Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation

Published:2022-08-17 Issue:8 Volume:60 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Hall Victoria G.¹²^ORCID,Humar Atul¹,Kumar Deepali¹^ORCID

Affiliation:

1. Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada

2. Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Abstract

Cytomegalovirus (CMV) is one of the most important viral complications after solid organ transplantation (SOT). Current preventive and management strategies rely primarily on serologic and viral load testing and remain suboptimal.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.01716-21

Reference51 articles.

1. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

2. State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician

3. The “ABC” of Virus-Specific T Cell Immunity in Solid Organ Transplantation

4. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

5. Immunobiology of Human Cytomegalovirus: from Bench to Bedside

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

2. Cellular immunity against cytomegalovirus and risk of infection after kidney transplantation;Frontiers in Immunology;2024-06-28

3. Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?;Transplant Infectious Disease;2024-05-10

4. Tailoring cytomegalovirus prophylaxis based on T cell immunity panel assessment in kidney transplant patients at high risk of cytomegalovirus;Transplant Infectious Disease;2024-05-06

5. Cytomegalovirus infection in heart transplant recipients: Epidemiology, risk factors, and long-term outcomes from a major transplant center in the United States;JHLT Open;2024-05